Buy Revance Therapeutics Stock | RVNC Stock Price & Latest News | Public
RVNC

Revance Therapeutics

$0.00 (0.00%)Today

    About RVNC

    Revance Therapeutics, Inc. is a clinical stage biotechnology company. It engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulin...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.38
    -0.77
    -1.15
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.12

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,65B
    Volume11,39k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$34.62
    1 Year Low$11.78
    Open$25.00
    High$25.18
    Low$23.95

    Buy any stock with any amount of money.

    Download the App
    Download the app